Laiba Immad

Contributing Author

Recent Articles by Laiba Immad

Sep-21	Absci Corporation (ABSI) Secures $64M Financing to Drive AI Drug Discovery Through 2028 ABSI Insider Monkey
Sep-21	New CMO Appointment Strengthens AbCellera Biologics Inc. (ABCL)'s Push Into Immunology and Beyond ABCL Insider Monkey
Sep-21	Recursion Pharmaceuticals, Inc. (RXRX) Secures $12.5M Milestone From Rallybio as REV102 Advances RXRX Insider Monkey
Sep-21	Relay Therapeutics, Inc. (RLAY) Shows Breakthrough Breast Cancer Results With RLY-2608 RLAY Insider Monkey
Sep-21	Moderna, Inc. (MRNA) Advances Flu, RSV, and Cancer mRNA Therapies Beyond COVID MRNA Insider Monkey
Sep-21	Structure Therapeutics Inc. (GPCR) Eyes Major 2025 Catalyst With Phase 2b Obesity Data GPCR Insider Monkey
Sep-21	Gilead Sciences, Inc. (GILD) Expands U.S. Manufacturing Capacity With $32B Investment Through 2030 GILD Insider Monkey
Sep-21	Pfizer Inc. (PFE) Pushes Forward in Cancer and Hemophilia Treatments PFE Insider Monkey
Sep-21	AbbVie Inc. (ABBV) Extends Rinvoq Patent to 2037, Delaying Generics ABBV Insider Monkey
Sep-21	Boston Scientific Corporation (BSX) Expands AI-Enhanced Heart Devices With FARAPULSE Approval BSX Insider Monkey
Sep-18	Perrigo Company plc (PRGO) Reports $1.06B Q2 Sales, Advances 'Three-S' Strategy PRGO Insider Monkey
Sep-18	AptarGroup, Inc. (ATR) Sees Pharma Segment Momentum Driving Record Earnings Growth ATR Insider Monkey
Sep-18	Danaher Corporation (DHR) Among Most Oversold Stocks, Gains Attention with Strategic Biotech Moves DHR Insider Monkey
Sep-18	Inspire Medical Systems, Inc. (INSP) Navigates Market Pressure from GLP-1 Drugs, Plans 2026 Growth INSP Insider Monkey
Sep-18	Integer Holdings Corporation (ITGR) Posts 11% Q2 Sales Growth Despite Stock Hitting 52-Week Low ITGR Insider Monkey
Sep-18	Summit Therapeutics Inc. (SMMT) Faces Volatile 2025 as Ivonescimab Gains Approval in China SMMT Insider Monkey
Sep-18	Glaukos Corporation (GKOS) Advances Next-Gen Glaucoma and Corneal Therapies, Eyes FDA Approval for Epioxa GKOS Insider Monkey
Sep-18	Qiagen N.V. (QGEN) Rolls Out QIAstat-Dx Rise, Expands U.S. Testing Access QGEN Insider Monkey
Sep-18	Telix Pharmaceuticals Limited (TLX) Increases R&D by 47%, Progresses Key Prostate and Brain Cancer Trials TLX Insider Monkey
Sep-18	Prestige Consumer Healthcare Inc. (PBH) Moves to Stabilize Eye Care Amid 2025 Headwinds PBH Insider Monkey
Sep-18	Bio-Rad Laboratories, Inc. (BIO) Launches New Instruments, Boosts Molecular Testing Reach BIO Insider Monkey
Sep-18	Haemonetics Corporation (HAE) Launches PerQseal Elite, Advancing Minimally Invasive Vascular Care HAE Insider Monkey
Sep-18	Soleno Therapeutics, Inc. (SLNO) Targets EMA Approval as U.S. Launch of VYKAT XR Expands SLNO Insider Monkey
Sep-16	Bausch Health Companies Inc. (BHC) Acquires DURECT in $413 Million Deal to Tackle Alcoholic Hepatitis BHC Insider Monkey
Sep-16	Viatris Inc. (VTRS) Enters $515M IV Iron Market With FDA Green Light VTRS Insider Monkey
Sep-16	Jazz Pharmaceuticals plc (JAZZ) Wins FDA Nod for Modeyso in Rare Pediatric Brain Tumors JAZZ Insider Monkey
Sep-16	Dental Giant DENTSPLY SIRONA Inc. (XRAY) Keeps Wellspect Unit Amid Strong Market Potential XRAY Insider Monkey
Sep-16	Perrigo Company plc (PRGO) Sells Dermacosmetics Unit in 327M Deal PRGO Insider Monkey
Sep-16	Royalty Pharma plc (RPRX) Reports 20% Portfolio Growth, Posts $727M in Q2 Receipts RPRX Insider Monkey
Sep-16	Bristol-Myers Squibb Company (BMY)-BioNTech Lung Cancer Therapy Shows 76% Tumor Reduction BMY Insider Monkey
Sep-16	Teva Pharmaceutical Industries Limited (TEVA)'s Emrusolmin Gains FDA Fast Track for Multiple System Atrophy TEVA Insider Monkey
Sep-16	Phase 3 Data Supports FDA Approval for Pfizer Inc. (PFE)'s 2025-2026 COVID-19 Vaccine PFE Insider Monkey
Sep-16	Universal Health Services, Inc. (UHS) Q2 Revenue Climbs Nearly 10% on Medicaid Boosts UHS Insider Monkey
Sep-16	Teleflex Incorporated (TFX) Plans 2026 Split into Two Independent Companies TFX Insider Monkey
Sep-11	Galapagos NV (GLPG)' CAR-T Therapy Hits 97% Response Rate in Lymphoma Trial GLPG Insider Monkey
Sep-11	Caris Life Sciences, Inc. (CAI) Secures FDA Nod for Revolutionary Tumor Profiling Test CAI Insider Monkey
Sep-11	Arcutis Biotherapeutics, Inc. (ARQT) Eyes Pediatric Expansion for ZORYVE Cream ARQT Insider Monkey
Sep-11	argenx SE (ARGX) Expands Autoimmune Leadership with Vyvgart Launch ARGX Insider Monkey
Sep-11	Incyte Corporation (INCY) Advances KRAS Cancer Program INCY Insider Monkey
Sep-11	PTC Therapeutics, Inc. (PTCT) Launches SUFIANCE for PKU PTCT Insider Monkey
Sep-11	Genmab A/S (GMAB) Scores FDA Breakthrough for Rina-S GMAB Insider Monkey
Sep-11	Metsera, Inc. (MTSR)'s MET-233i Shows 8% Weight Loss in Phase 1 MTSR Insider Monkey
Sep-11	CRISPR Therapeutics AG (CRSP)'s Casgevy Expands Global Adoption in 2025 CRSP Insider Monkey
Sep-11	ACADIA Pharmaceuticals Inc. (ACAD) Nears Key Phase 3 Readout in Prader-Willi Syndrome ACAD Insider Monkey
Sep-11	Royalty Pharma plc (RPRX) Commits $300M to Zenas' Obexelimab Program RPRX Insider Monkey
Sep-11	Qiagen N.V. (QGEN) Launches QIAseq xHYB Panels for Long-Read Sequencing QGEN Insider Monkey
Sep-11	Humana Inc. (HUM) Expands Beyond Insurance Into Healthcare Services HUM Insider Monkey
Sep-11	LeMaitre Vascular, Inc. (LMAT) Gains Edge in Niche Vascular Device Market LMAT Insider Monkey
Sep-11	ResMed Inc. (RMD) Launches Global Sleep Institute at World Sleep Congress RMD Insider Monkey
Sep-11	Roivant Sciences Ltd. (ROIV) Wins Orphan Drug Status in Japan for Mosliciguat ROIV Insider Monkey
Sep-11	Omega Healthcare Investors, Inc. (OHI) Expands Senior Care Portfolio With $502M Acquisitions OHI Insider Monkey
Sep-11	Grifols, S.A. (GRFS) to Double Plasma Production With New Spain Facility GRFS Insider Monkey
Sep-02	Harrow, Inc. (HROW) Emerges as Eye Care Powerhouse With Biosimilars to Lucentis and Eylea HROW Insider Monkey
Sep-02	Collegium Pharmaceutical, Inc. (COLL) to Present 9 Pain Studies at PAINWeek 2025 COLL Insider Monkey
Sep-02	ANI Pharmaceuticals, Inc. (ANIP) Hits Milestone with Cortrophin Gel Prefilled Syringe Launch ANIP Insider Monkey
Sep-02	Amphastar Pharmaceuticals, Inc. (AMPH) Secures FDA Approval for Generic Iron Sucrose Injection AMPH Insider Monkey
Sep-02	Avadel Pharmaceuticals plc (AVDL)'s LUMRYZ Sales Surge 64% in Breakout Quarter AVDL Insider Monkey
Sep-02	FDA Accepts Lantheus Holdings, Inc. (LNTH)' NDA for New PSMA Imaging Agent LNTH Insider Monkey
Sep-02	Dynavax Technologies Corporation (DVAX) Reports Record $92M HEPLISAV-B Revenue, Raises 2025 Outlook DVAX Insider Monkey
Sep-02	Novo Nordisk A/S (NVO) Wins U.S. Wegovy Approval for MASH, Expands to China Market NVO Insider Monkey
Sep-02	BioCryst Pharmaceuticals, Inc. (BCRX) Q2 Revenue Soars 49%, Hits Record $163.4 Million on ORLADEYO Surge BCRX Insider Monkey
Sep-02	Neurocrine Biosciences, Inc. (NBIX) Beats Estimates on Neurology Drug Demand, Expands Payer Access NBIX Insider Monkey
Sep-02	Eli Lilly and Company (LLY)'s Oral Obesity Drug Orforglipron Achieves Breakthrough Phase 3 Results LLY Insider Monkey
Sep-02	NRx Pharmaceuticals, Inc. (NRXP)' NRX-100 Wins Expanded FDA Fast Track for Suicidal Depression NRXP Insider Monkey
Sep-02	Psyence Biomedical Ltd. (PBM) Achieves Breakthrough in High-Purity Ibogaine Production PBM Insider Monkey
Sep-02	Relmada Therapeutics, Inc. (RLMD) Reports 91% Response Rate in Phase 2 Bladder Cancer Study RLMD Insider Monkey
Sep-02	Cybin Inc. (CYBN) Launches Global Phase 3 Trial for Breakthrough Depression Therapy CYBN Insider Monkey
Sep-02	GH Research PLC (GHRS) Reports 73% Remission in Phase 2b Depression Trial GHRS Insider Monkey
Sep-02	Vistagen Therapeutics, Inc. (VTGN) Eyes Breakthrough with Phase 3 Social Anxiety Trial VTGN Insider Monkey
Sep-02	Bright Minds Biosciences Inc. (DRUG) Advances Phase 2 Trial for Drug-Resistant Epilepsy DRUG Insider Monkey
Sep-02	Neuronetics, Inc. (STIM) Positions as Neurohealth Leader with Adolescent Breakthrough STIM Insider Monkey
Sep-02	Atai Life Sciences N.V. (ATAI)'s BPL-003 Achieves Robust Phase 2b Success in Treatment-Resistant Depression ATAI Insider Monkey
Sep-02	Mind Medicine (MindMed) Inc. (MNMD)'s MM120 Earns FDA Breakthrough Status in Anxiety Treatment MNMD Insider Monkey
Sep-02	COMPASS Pathways Plc (CMPS)' Psilocybin Therapy Hits Phase 3 Success in Depression CMPS Insider Monkey
Sep-02	Alkermes plc (ALKS) Completes Enrollment in Key Narcolepsy Trial, Data Due Q3 2025 ALKS Insider Monkey
Sep-02	Biogen Inc. (BIIB)'s Alzheimer's Drug Leqembi Wins EU Nod, Now Approved in 48 Countries BIIB Insider Monkey
Sep-02	Amgen Inc. (AMGN)'s Experimental Obesity Drug MariTide Shows Up to 20% Weight Loss Potential AMGN Insider Monkey
Sep-02	Bristol-Myers Squibb Company (BMY) Launches $300M Immunology Spinout with Bain Capital BMY Insider Monkey
Sep-02	Gilead Sciences, Inc. (GILD) Wins FDA Approval for World's First Twice-Yearly HIV Preventive Therapy GILD Insider Monkey
Sep-02	Zoetis Inc. (ZTS) Reports $2.5B Q2 Revenue, Raises Full-Year Outlook on Strong Pet Care Demand ZTS Insider Monkey
Sep-02	Pfizer Inc. (PFE)'s Updated COVID-19 Vaccine COMIRNATY LP.8.1 Gets FDA Approval, Ships Nationwide PFE Insider Monkey
Sep-02	AbbVie Inc. (ABBV) Acquires Psychedelic Drug Developer Gilgamesh for $1.2B, Enters Mental Health Market ABBV Insider Monkey
Sep-02	Merck & Co., Inc. (MRK) Launches $3B Plan to Reinvest Ahead of Keytruda Patent Expiry in 2028 MRK Insider Monkey
Sep-02	Johnson & Johnson (JNJ)'s Carvykti Sales Skyrocket 100% Amid Specialty Medicine Growth JNJ Insider Monkey
Sep-02	Eli Lilly and Company (LLY) Halts UK Mounjaro Shipments Ahead of Planned Price Increase LLY Insider Monkey
Aug-29	Genmab A/S (GMAB)'s Epcoritamab Delivers 95% Response in Lymphoma GMAB Insider Monkey
Aug-29	Sanofi (SNY)'s Sarclisa Gets EMA Nod for Multiple Myeloma SNY Insider Monkey
Aug-29	MiMedx Group, Inc. (MDXG) Partners with Vaporox for Advanced Wound Therapy MDXG Insider Monkey
Aug-29	MannKind Corporation (MNKD) Seeks FDA Pediatric Approval for Afrezza MNKD Insider Monkey
Aug-29	Ardelyx, Inc. (ARDX) Strengthens Global Reach with Kyowa Kirin Deal ARDX Insider Monkey
Aug-29	Xeris Biopharma Holdings, Inc. (XERS) Reports Record $71.5M Q2 Revenue XERS Insider Monkey
Aug-29	Wave Life Sciences Ltd. (WVE) Gains Momentum With Multiple RNA Wins WVE Insider Monkey
Aug-29	Amicus Therapeutics, Inc. (FOLD) Expands Pipeline With Rare Kidney Disease Drug FOLD Insider Monkey
Aug-29	Collegium Pharmaceutical, Inc. (COLL) Highlights Real-World Evidence at PAINWeek 2025 COLL Insider Monkey
Aug-29	Ardent Health, Inc. (ARDT) Expands Footprint with 18 New Urgent Care Clinics in 2025 ARDT Insider Monkey
Aug-29	Integra LifeSciences Holdings Corporation (IART) Focuses on Supply Chain Recovery and Growth Strategy IART Insider Monkey
Aug-29	Bausch Health Companies Inc. (BHC) Expands Hepatology Portfolio with DURECT Acquisition BHC Insider Monkey
Aug-29	CorMedix Inc. (CRMD) Acquires Melinta Therapeutics to Expand Hospital-Focused Portfolio CRMD Insider Monkey
Aug-29	Royalty Pharma plc (RPRX) Boosts Growth with $885M Amgen Imdelltra Royalty Deal RPRX Insider Monkey
Aug-29	Organon & Co. (OGN) Advances VTAMA Cream, Strengthens Women's Health Portfolio OGN Insider Monkey

Laiba Immad

Recent Articles by Laiba Immad

Upgrade your FINVIZ experience